Answer
Riociguat is not recommended in patients with pulmonary veno-occlusive disease because pulmonary vasodilators may significantly worsen their cardiovascular status.
Sources for this answer
- Adempas 0.5 mg, 1.0 mg, 1.5 mg, 2.0 mg, 2.5 mg film-coated tabletsMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.4 Special warnings and precautions for use · Version 16Document updated
Sources checked